Allient
Allient's revenue rose 4.6% to $554 million in fiscal 2025. Its operating margin was 7.9%, up from 5.7% a year earlier. Free cash flow was $50 million, up 54.5%. It paid out $2 million in dividends and buybacks, 4% of free cash flow. The diluted share count rose 0.8%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
What Allient does
Allient designs and makes motion control components and systems: motors, drives, controllers, encoders, positioning systems and power quality filters. These go into industrial, vehicle, medical, and aerospace and defense products. It sells to end customers and equipment makers through its own sales force and through authorized representatives and distributors.
It is headquartered in Amherst, New York, and sells in the United States, Canada, South America, Europe and Asia-Pacific. It grew partly through acquisitions, including a maker of electrical transformers in 2024. In 2024 it began a program to realign its factories and streamline the organization.
At December 31, 2025, Allient employed 2,478 full-time employees worldwide, with approximately 63% of them in North America.
Its biggest risks, as it describes them
- Economic, trade and currency risks from selling and making products around the world.
- Lower demand if the markets it serves shrink or go through cycles.
- Tariffs and other trade barriers that could raise its costs.
- Customer order swings tied to price changes and inventory levels.
- Trouble carrying out its factory realignment and acquisitions.
Income statement
From fiscal 2016 to 2025, earnings per share grew 7.8% a year and net income 10.3% a year, as new shares raised the share count by 22% and diluted each share's earnings.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 22 | 31 | 32 | 36 | 41 |
| Debt incl. finance leases | 159 | 245 | 227 | 233 | 189 |
| Net debt (negative means net cash) | 136 | 214 | 196 | 197 | 148 |
| Net debt to EBITDA | 3.1x | 3.8x | 2.9x | 3.5x | 2.1x |
| Debt to equity | 0.8x | 1.1x | 0.9x | 0.9x | 0.6x |
| Interest coverage | 8.0x | 4.1x | 3.4x | 2.3x | 3.3x |
| Current ratio | 2.2x | 2.7x | 2.6x | 4.1x | 3.7x |
| Quick ratio | 1.1x | 1.4x | 1.4x | 2.2x | 2.1x |
Cash flow
Projections
Project Allient's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
Over the 12 months between November 20, 2025 and November 19, 2026, 1 insider bought $97,104 of Allient shares on the open market, and 3 insiders sold $9.3 million.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 23, 2026 | Michael R WinterDirector | Sold | 457 | $109.27 | $49,936 | Form 4 |
| Sep 23, 2026 | Michael R WinterDirector | Bought | 457 | $108.97 | $49,799 | Form 4 |
| Aug 10, 2026 | Richard S WarzalaChief Executive Officer, Director | Sold | 70,000 | $113.58 | $8.0 million | Form 4 |
| Mar 27, 2026 | Ashish BendreVP and Group President | Sold | 6,000 | $63.00 | $378,000 | Form 4 |
| Dec 23, 2025 | Michael R WinterDirector | Bought | 847 | $55.85 | $47,305 | Form 4 |
| Dec 23, 2025 | Michael R WinterDirector | Sold | 847 | $55.56 | $47,059 | Form 4 |
| Nov 25, 2025 | Ashish BendreVP and Group President | Sold | 16,000 | $52.25 | $836,000 | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | 6 of 9 | 4 of 9 | 7 of 9 |
| Rule of 40 | 20.8% | −2.3% | 13.6% |
| Altman Z'' | 3.82 | 4.30 | 4.86 |
| Accruals ratio | −3.5% | −4.9% | −6.0% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Pass | Fail | Pass |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Fail | Pass |
| Current ratio rose | Fail | Pass | Fail |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | Pass | Fail | Pass |
| Revenue rose relative to assets | Fail | Fail | Pass |
| F-score | 6 of 9 | 4 of 9 | 7 of 9 |
Compare
Put Allient side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Allient | FY25 | 4.6% | 7.9% | 9.0% | 7.4% | 2.1x | 7 | |
| GrafTech International | FY25 | −6.4% | −15.3% | −23.9% | −8.4% | — | 2 | Compare |
| Shoals Technologies Group | FY25 | 19.1% | 11.9% | −3.4% | — | — | — | Compare |
| Preformed Line Products | FY25 | 12.7% | 8.2% | 5.0% | 10.2% | −0.5x | 6 | Compare |
| Vicor | FY25 | 26.1% | 18.1% | 26.3% | — | — | — | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 246 | 252 | 311 | 371 | 367 | 404 | 503 | 579 | 530 | 554 |
| Revenue growth | 5.8% | 2.5% | 23.2% | 19.5% | −1.2% | 10.0% | 24.6% | 15.0% | −8.4% | 4.6% |
| Gross profit | 73 | 76 | 91 | 113 | 109 | 121 | 157 | 184 | 166 | 182 |
| Research and development | — | — | — | — | — | — | — | — | — | — |
| Operating income | 19 | 19 | 23 | 29 | 23 | 26 | 32 | 42 | 30 | 44 |
| Net income | 9 | 8 | 16 | 17 | 14 | 24 | 17 | 24 | 13 | 22 |
| Diluted EPS (US$) | 0.67 | 0.58 | 1.13 | 1.20 | 0.95 | 1.66 | 1.09 | 1.48 | 0.79 | 1.32 |
| Diluted shares (millions) | 14 | 14 | 14 | 14 | 14 | 14 | 16 | 16 | 17 | 17 |
| Cash flow | ||||||||||
| Cash from operations | 14 | 25 | 18 | 34 | 25 | 25 | 6 | 45 | 42 | 57 |
| Capital expenditure | 5 | 6 | 14 | 15 | 9 | 14 | 16 | 12 | 10 | 7 |
| Free cash flow | 9 | 19 | 3 | 20 | 15 | 12 | −10 | 33 | 32 | 50 |
| Dividends paid | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 16 | 0 | 77 | 0 | 15 | 47 | 44 | 11 | 25 | 0 |
| Stock-based compensation | — | — | — | 3 | 4 | 4 | 5 | 6 | 4 | 3 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 16 | 16 | 9 | 13 | 23 | 22 | 31 | 32 | 36 | 41 |
| Debt incl. finance leases | 70 | 53 | 122 | 110 | 120 | 159 | 245 | 227 | 233 | 189 |
| Total assets | 180 | 188 | 285 | 306 | 349 | 471 | 588 | 598 | 576 | 578 |
| Total liabilities | 108 | 101 | 184 | 187 | 206 | 283 | 373 | 346 | 311 | 276 |
| Shareholders' equity | 72 | 87 | 102 | 119 | 143 | 188 | 216 | 252 | 265 | 302 |
| Margins and ratios | ||||||||||
| Gross margin | 29.7% | 30.0% | 29.4% | 30.3% | 29.6% | 30.0% | 31.3% | 31.7% | 31.3% | 32.8% |
| Operating margin | 7.7% | 7.5% | 7.5% | 7.9% | 6.3% | 6.5% | 6.3% | 7.3% | 5.7% | 7.9% |
| Net margin | 3.7% | 3.2% | 5.1% | 4.6% | 3.7% | 6.0% | 3.5% | 4.2% | 2.5% | 4.0% |
| Free cash flow margin | 3.7% | 7.6% | 1.0% | 5.3% | 4.2% | 2.9% | −2.0% | 5.8% | 6.1% | 9.0% |
| Rule of 40 (growth + FCF margin) | 9.5% | 10.1% | 24.3% | 24.8% | 3.0% | 12.9% | 22.6% | 20.8% | −2.3% | 13.6% |
| Return on capital | 11.2% | 7.5% | 10.5% | 9.8% | 7.3% | 9.2% | 6.2% | 7.8% | 5.2% | 7.4% |
| Return on equity | 13.3% | 10.1% | 16.8% | 15.4% | 10.4% | 14.6% | 8.6% | 10.3% | 5.1% | 7.8% |
| Return on assets | 5.3% | 4.4% | 6.7% | 5.8% | 4.2% | 5.9% | 3.3% | 4.1% | 2.2% | 3.8% |
| Net debt to EBITDA | 1.9x | 1.3x | 3.3x | 2.2x | 2.5x | 3.1x | 3.8x | 2.9x | 3.5x | 2.1x |